4-(4-Fluorobenzoyl)-3-hydroxymethylbenzonitrile is an intermediate in the synthesis of Citalopram/Escitalopram, a selective serotonin reuptake inhibitor that relieves the symptoms of diabetes and is used in the treatment of depression.
參考文獻
Andersen, G., et al.: Stroke, 25, 1099 (1994); Sindrup, S., et al.: Clin. Pharmacol. Ther., 52, 547 (1992)
滬ICP備17019645號
400-821-0725
